Summit Therapeutics Inc. (SMMT)

Summit Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-921.62	-221.32	-614.93	-78.78	-88.6	-52.7
Depreciation & Amortization	0.13	0.09	0.2	1.26	2.46	2
Loss (Gain) From Sale of Assets	-	-	-0.11	-	-	-
Asset Writedown & Restructuring Costs	-	15.01	521.39	8.47	-	0.86
Loss (Gain) From Sale of Investments	-1.64	-2.58	-1.92	-	-	-
Stock-Based Compensation	631.66	50.98	14.11	11.95	12.8	1.77
Other Operating Activities	-0.59	0.23	5.02	5.65	0.82	-0.66
Change in Accounts Receivable	-	-	0.36	0.98	-1.14	0.21
Change in Accounts Payable	18.98	2.02	2.26	-4.13	-1.71	1.64
Change in Unearned Revenue	-	-	-	-7.28	-0.81	5.37
Change in Other Net Operating Assets	3.42	13.46	-3.14	20.3	3.6	-6.61
Operating Cash Flow	-269.67	-142.11	-76.76	-41.58	-72.59	-48.11
Capital Expenditures	-0.51	-0.14	-0.13	-0.62	-0.31	-0.42
Sale of Property, Plant & Equipment	-	-	0.23	-	-	-
Sale (Purchase) of Intangibles	-	-15.01	-475.02	-	-	-
Investment in Securities	394.84	-190.2	-112.86	-	-	-
Investing Cash Flow	394.33	-205.34	-587.77	-0.62	-0.31	-0.42
Short-Term Debt Issued	-	-	-	-	110	-
Long-Term Debt Issued	-	-	-	545	-	-
Total Debt Issued	-	-	-	545	110	-
Short-Term Debt Repaid	-	-	-	-	-110	-
Long-Term Debt Repaid	-	-100	-24.69	-25	-	-
Total Debt Repaid	-24.5	-100	-24.69	-25	-110	-
Net Debt Issued (Repaid)	-24.5	-100	-24.69	520	-	-
Issuance of Common Stock	44.6	481.23	111.82	100.4	78.09	50.6
Other Financing Activities	-	-	-0.62	-0.16	-0.17	-0.05
Financing Cash Flow	20.1	381.23	86.51	620.24	77.92	50.55
Foreign Exchange Rate Adjustments	0.01	-0.02	0.84	-1.22	0.35	0.56
Net Cash Flow	144.78	33.76	-577.18	576.82	5.37	2.58
Free Cash Flow	-270.17	-142.25	-76.89	-42.21	-72.89	-48.53
Free Cash Flow Margin	-	-	-	-5986.67%	-4029.46%	-5643.26%
Free Cash Flow Per Share	-0.36	-0.20	-0.12	-0.22	-0.79	-0.70
Cash Interest Paid	7.31	8.81	10.65	0.43	0.09	-
Cash Income Tax Paid	-	-	0.05	-	-	-0.07
Levered Free Cash Flow	73.8	-88.94	-221.68	-319.72	-38.3	-28.79
Unlevered Free Cash Flow	73.8	-83.51	-211.39	-316.97	-38.15	-28.63
Change in Working Capital	22.39	15.48	-0.52	9.87	-0.07	0.62

Updated Oct 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q